ÂÜÀòÂÒÂ×

John Mulcahy, PhD, is Chief Executive Officer of SiteOne Therapeutics. From 2012–2020 he served as Vice President of Research, leading the company’s drug discovery efforts across multiple targets and therapeutic areas. During this period he served as Project Lead for a multiyear research and development collaboration with Amgen, and Principal Investigator on multiple grants from the United States Department of Defense and National Institutes of Health. Prior to founding SiteOne, Dr. Mulcahy completed a postdoctoral fellowship in the Department of Anesthesiology at the Stanford School of Medicine, a PhD in Chemistry from Stanford University, and an AB in Chemistry, Physics and Classics from Harvard College.